XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stockholders’ Deficit | 6 Months Ended
--- | ---
Jun. 30, 2024
Stockholders' Equity Note [Abstract] |
Stockholders’ Deficit | Stockholders’ Deficit Common stock The Company’s amended and restated certificate of incorporation authorizes the issuance of Class A common stock, Class B common stock, and Class C common stock. Holders of Class A common stock, Class B common stock, and Class C common stock are entitled to dividends on a pro rata basis, when, as, and if declared by the Company’s Board of Directors, subject to the rights of the holders of the Company’s preferred stock. Holders of Class A common stock are entitled to one vote per share, holders of Class B common stock are entitled to 10 votes per share, and holders of Class C common stock are entitled to zero votes per share. As of June 30, 2024, the Company had authorized 2,400.0 million shares of Class A common stock, 475.0 million shares of Class B common stock, and 800.0 million shares of Class C common stock, each at par value of $0.00001. Holders of Class B common stock voluntarily converted 0.3 million and 1.0 million shares during the three and six months ended June 30, 2024, respectively, and 0.5 million and 1.0 million shares into an equivalent number of shares of Class A common stock during the three and six months ended June 30, 2023, respectively. As of June 30, 2024, 238.9 million shares of Class A common stock, 79.8 million shares of Class B common stock, and no shares of Class C common stock were issued and outstanding. As of December 31, 2023, 256.0 million shares of Class A common stock, 80.7 million shares of Class B common stock, and no shares of Class C common stock were issued and outstanding. Class A shares issued and outstanding as of June 30, 2024 and December 31, 2023 exclude unvested restricted stock awards granted to certain executives. Class A shares issued and outstanding also exclude 8.3 million unvested restricted stock awards granted to one of the Company's co-founders as of June 30, 2024 and December 31, 2023, resp ectively. See "Co-Founder Grant" section below for further details. Preferred stock The Company's Board of Directors will have the authority, without further action by the Company's stockholders, to issue up to 240.0 million shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time-to-time by the Board of Directors. Stock repurchase program In February 2022, the Board of Directors authorized the Company to repurchase up to $1.2 billion of the Company's outstanding shares of Class A common stock. In July 2023, the Board of Directors further authorized the repurchase of up to an additional $1.2 billion of the outstanding shares of our Class A common stock. The Company completed the February 2022 authorization of $1.2 billion during the three months ended March 31, 2024 and continued stock repurchases under the July 2023 authorization. Share repurchases will be made from time-to-time in private transactions or open market purchases, as permitted by securities laws and other legal requirements and will be subject to a review of the circumstances in place at that time, including prevailing market prices. The program does not obligate the Company to repurchase any specific number of shares and may be discontinued at any time. During the three and six months ended June 30, 2024, the Company repurchased and subsequently retired 11.3 million and 22.4 million shares of its Class A common stock, respectively, for an aggregate amount of $262.2 million and $543.8 million, respectively. During the three and six months ended June 30, 2023, the Company repurchased and subsequently retired 6.9 million and 15.0 million shares of its Class A common stock, respectively, for an aggregate amount of $155.2 million and $331.7 million, respectively. During the three and six months ended June 30, 2024 and 2023, i ncluded in the cost of treasury stock acquired pursuant to common share repurchases, is the 1% excise tax imposed as part of the Inflation Reduction Act. Equity incentive plans Under the 2018 Plan, the Company may grant stock-based awards to purchase or directly issue shares of common stock to employees, directors, and consultants. Options are granted at a price per share equal to the fair market value of the Company's common stock at the date of grant. Options granted are exercisable over a maximum term of 10 years from the date of grant and generally vest over a period of four years. RSUs and RSAs are also granted under the 2018 Plan. The 2018 Plan will terminate 10 years after the later of (i) its adoption or (ii) the most recent stockholder-approved increase in the number of shares reserved under the 2018 Plan, unless terminated earlier by the Company's Board of Directors. The 2018 Plan was adopted on March 22, 2018. In connection with the acquisition of DocSend, the Company assumed unvested stock options and an immaterial number of unvested RSUs that had been granted under DocSend's 2013 Stock Plan and DocSend's 2015 Stock Option and Grant Plan. As of June 30, 2024, there were 35.7 million stock-based awards issued and outstanding and 117.3 million shares available for issuance under the Dropbox Equity Incentive Plans, Dropbox Sign's 2011 Equity Incentive Plan, DocSend's 2013 Stock Plan and DocSend's 2015 Stock Option and Grant Plan (collectively, the "Plans"). Stock option and restricted stock activity for the Plans was as follows for the six months ended June 30, 2024:
|  |  | Options outstanding |  | Restricted stock outstanding
| Number of shares available for issuance under the Plans |  | Number of shares outstanding under the Plans |  | Weighted- average exercise price per share |  | Weighted- average remaining contractual term (In years) |  | Aggregate intrinsic value |  | Number of shares outstanding under the Plans |  | Weighted- average grant date fair value per share
Balance at December 31, 2023 | 110.0 |  |  | 0.2 |  |  | $ | 13.54 |  |  | 3.9 |  | $ | 2.2 |  |  | 30.4 |  |  | $ | 23.16 |
Additional shares authorized | 16.8 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Options exercised and restricted stock units and awards released | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7.1) |  |  | 23.45 |
Options and restricted stock units and awards canceled | 3.2 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3.2) |  |  | 23.90 |
Shares withheld related to net share settlement of restricted stock units and awards | 2.7 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Options and restricted stock units and awards granted | (15.4) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 15.4 |  |  | 24.53 |
Balance as of June 30, 2024 | 117.3 |  |  | 0.2 |  |  | $ | 14.67 |  |  | 3.3 |  | $ | 0.9 |  |  | 35.5 |  |  | $ | 23.63 |
Vested at June 30, 2024 |  |  | 0.2 |  |  | $ | 14.67 |  |  | 3.3 |  | $ | 0.9 |  |  | — |  |  | $ | — |
Unvested at June 30, 2024 |  |  | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | 35.5 |  |  | $ | 23.63 |
The following table summarizes information about the pre-tax intrinsic value of options exercised during the three and six months ended June 30, 2024 and 2023:
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Intrinsic value of options exercised | $ | 0.2 |  |  | $ | 1.3 |  |  | $ | 0.4 |  |  | $ | 2.2 |
As of June 30, 2024, unamortized stock-based compensation related to unvested stock options, restricted stock awards (excluding the Co-Founder Grant), and RSUs was $822.1 millio n. The weighted-average period over which such compensation expense will be recognized if the requisite service is provided is approximately 2.8 years as of June 30, 2024. Co-Founder Grant In December 2017, the Board of Directors approved the Company's Co-Founder Grant, consisting of 10.3 million shares of Class A common stock in the form of RSAs which were granted to Drew Houston, the Company’s co-founder and Chief Executive Officer. This Co-Founder Grant has service-based, market-based, and performance-based vesting conditions. The Co-Founder Grant is excluded from Class A common stock issued and outstanding until the satisfaction of these vesting conditions. The Co-Founder Grant also provides the holder with certain stockholder rights, such as the right to vote the shares with the other holders of Class A common stock and a right to cumulative declared dividends. The Co-Founder Grant is eligible to vest over the ten-year period following the date the Company’s shares of Class A common stock commenced trading on the Nasdaq Global Select Market in connection with the Company’s IPO. The Co-Founder Grant is comprised of nine tranches that are eligible to vest based on the achievement of stock price goals, each of which are referred to as a Stock Price Target, measured over a consecutive thirty-day trading period during the Performance Period. The Performance Period began on January 1, 2019. During the first four years of the Performance Period, no more than 20% of the shares subject to the Co-Founder Grant would be eligible to vest in any calendar year. After the first four years, all shares are eligible to vest based on the achievement of the Stock Price Targets. The first tranche of the Co-Founder Grant, or 2.1 million shares of Class A common stock, vested in the fourth quarter of 2021. The stock-based compensation expense for Mr. Houston's Co-Founder Grant is recognized utilizing the accelerated attribution method over the requisite service period identified as the derived service period over which the market conditions are expected to be achieved, and is not reversed if the market conditions are not satisfied. Therefore no incremental stock-based compensation was recognized upon vesting of these RSAs. The Company recognized stock-based compensation expense related to the Co-Founder Grant of $0.7 million and $1.8 million during the three and six months ended June 30, 2024, respectively, and $2.0 and $4.2 during the three and six months ended June 30, 2023, respectively. As of June 30, 2024, unamortized stock-based compensation expense related to the Co-Founder Grant was $0.6 million.

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration